Soleus Capital Master Fund Reports New 5.1% Passive Stake in Inspire Medical Systems

Soleus Capital Master Fund, L.P., along with its affiliates and Guy Levy, filed a Schedule 13G on May 27, 2026, reporting a new 5.1% ownership stake in Inspire Medical Systems, Inc. (INSP). The group beneficially owns 1,470,748 shares of common stock as of the event date on May 26, 2026. This filing represents an initial crossing of the 5% beneficial ownership threshold for the reporting entities. Soleus Capital Master Fund directly holds the shares, while Soleus Capital, LLC, Soleus Capital Group, LLC, Soleus Capital Management, L.P., Soleus GP, LLC, and Guy Levy are identified as indirect beneficial owners due to their management and control structures. The filing was made under Rule 13d-1(c), indicating a passive investment intent rather than an attempt to influence control over the issuer. Guy Levy serves as the managing member for the controlling entities within the Soleus group. The ownership percentage is based on 28,813,153 shares outstanding as of April 28, 2026.